
- Volume 0 0
Venofer (iron sucrose injection, USP)
American Regent Inc(Shirley, NY) recentlyreceived FDA approval for2 new indications forVenofer. The product wasinitially approved for use in the treatmentof iron deficiency anemia inhemodialysis (HD) patients receivingan erythropoietin. Venofer now also isindicated for the treatment of irondeficiency anemia in peritoneal dialysis(PD) patients receiving an erythropoietinand in nondialysis chronic kidneydisease (CKD) patients receiving ornot receiving an erythropoietin. Theproduct can be administered via anintravenous push (100-mg [HD] and 200-mg [CKD] doses) or by infusion (300- and400-mg doses [PD]) depending on theindication. Venofer is available in 100-mg/5-mL single-dose vials. For moreinformation, visit www.venofer.com, orcall 800-645-1706.
Articles in this issue
over 19 years ago
A Good Night's Rest—Helping the Patient with Insomniaover 19 years ago
Is Sleep-Driving for Real?over 19 years ago
Painful Diabetic Neuropathy: Alternative Treatmentsover 19 years ago
A New Day Dawns for NCPA and NACDSover 19 years ago
compounding HOTLINEover 19 years ago
RESPy AWARDover 19 years ago
ULM STUDENT NEEDED TO HELPover 19 years ago
Must an Embezzling Pharmacist Repay Wages Received?over 19 years ago
Web-based Program Aids Health Care Industryover 19 years ago
Depression: Identifying Symptoms and Appropriate TreatmentNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.